Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review.
Barbieri M, Chiodini P, Di Gennaro P, Hafez G, Liabeuf S, Malyszko J, Mani LY, Mattace-Raso F, Pepin M, Perico N, Simeoni M, Zoccali C, Tortorella G, Capuano A, Remuzzi G, Capasso G, Paolisso G; CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target) collaborators.
Barbieri M, et al. Among authors: capuano a.
Pharmacol Res. 2024 May;203:107146. doi: 10.1016/j.phrs.2024.107146. Epub 2024 Mar 16.
Pharmacol Res. 2024.
PMID: 38493928
Free article.
Review.